Details for New Drug Application (NDA): 050579
✉ Email this page to a colleague
The generic ingredient in MONOCID is cefonicid sodium. Additional details are available on the cefonicid sodium profile page.
Summary for 050579
Tradename: | MONOCID |
Applicant: | Glaxosmithkline |
Ingredient: | cefonicid sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050579
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | May 23, 1984 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | May 23, 1984 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | May 23, 1984 | TE: | RLD: | No |
Complete Access Available with Subscription